Comments
Genomics Startup Learns From 23andme's Troubles
Newest First  |  Oldest First  |  Threaded View
Alison_Diana
50%
50%
Alison_Diana,
User Rank: Author
4/24/2014 | 10:25:26 AM
Disruption in Healthcare
As I recall, 23andme got into trouble because the FDA decided consumers might not be able to handle information about their own health -- even though consumers can't go out and order themselves a hyseteroctomy, masectomy, or other drastic surgery as the result of a genetic study. This startup definitely sidesteps that issue, although consumers could still shop around to find a surgeon willing to take more drastic action than a situation warrants, if they really want to. Personally, I'm not interested in this type of test: I know what my greats and grandparents died from and recognize diet, exercise, and low stress are beneficial; cholesterol, tobacco, and sugar are bad. 
Thomas Claburn
50%
50%
Thomas Claburn,
User Rank: Author
4/23/2014 | 2:54:46 PM
Re: What would you pay for a genomics-enhanced health assessment?
The problem is judging the value of a product that offers only statistical data. Unless the data shows a significant chance of getting a certain disease, it's of uncertain value. You can't really tell how much it's worth to know whether you have a 0.65% greater chance of getting a disease than the average person.  Absent a rational way to make the decision, you're not likely to have a health service that attracts a lot of customers.
danielcawrey
50%
50%
danielcawrey,
User Rank: Ninja
4/23/2014 | 1:09:40 PM
Re: What would you pay for a genomics-enhanced health assessment?
I don't know how much of the information I would really want. I mean, why would I want to spend time concerned about risk factors I might not be able to fully control? I think that would be my major issue. 

I get that with technology we are going to be able to see ahead a lot better about what's happening to our health. The problem is that I'm not sure everyone is going to want this. That's said, there will be some who will, creating a totally new market for health awareness. 
David F. Carr
50%
50%
David F. Carr,
User Rank: Author
4/23/2014 | 9:36:21 AM
What would you pay for a genomics-enhanced health assessment?
Would you pay out of pocket for a better glimpse at what your genetic makeup and lifestyle say about your future health?


The Business of Going Digital
The Business of Going Digital
Digital business isn't about changing code; it's about changing what legacy sales, distribution, customer service, and product groups do in the new digital age. It's about bringing big data analytics, mobile, social, marketing automation, cloud computing, and the app economy together to launch new products and services. We're seeing new titles in this digital revolution, new responsibilities, new business models, and major shifts in technology spending.
Register for InformationWeek Newsletters
White Papers
Current Issue
InformationWeek Tech Digest September 18, 2014
Enterprise social network success starts and ends with integration. Here's how to finally make collaboration click.
Flash Poll
Video
Slideshows
Twitter Feed
InformationWeek Radio
Sponsored Live Streaming Video
Everything You've Been Told About Mobility Is Wrong
Attend this video symposium with Sean Wisdom, Global Director of Mobility Solutions, and learn about how you can harness powerful new products to mobilize your business potential.